Diphenylpyraline
From Wikipedia, the free encyclopedia
Diphenylpyraline
|
|
Systematic (IUPAC) name | |
4-benzhydryloxy-1-methyl-piperidine | |
Identifiers | |
CAS number | 147-20-6 |
ATC code | R06AA07 |
PubChem | 3103 |
DrugBank | APRD00719 |
Chemical data | |
Formula | C19H23NO |
Mol. weight | 281.392 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Diphenylpyraline is an antihistamine.
[edit] External links
- Lapa G, Mathews T, Harp J, Budygin E, Jones S (2005). "Diphenylpyraline, a histamine H1 receptor antagonist, has psychostimulant properties.". Eur J Pharmacol 506 (3): 237-40. PMID 15627433.
- Ohno T, Kobayashi S, Hayashi M, Sakurai M, Kanazawa I (2001). "Diphenylpyraline-responsive parkinsonism in cerebrotendinous xanthomatosis: long-term follow up of three patients.". J Neurol Sci 182 (2): 95-7. PMID 11137513.
- Puhakka H, Rantanen T, Virolainen E (1977). "Diphenylpyraline (Lergobine) in the treatment of patients suffering from allergic and vasomotor rhinitis.". J Int Med Res 5 (1): 37-41. PMID 14039.